Showing results (1-10 of 513) with videos related to
Sort By:
Pageof 52
Pneumologie (Stuttgart, Germany)|May 14, 2015
[New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)]T Schaberg, R Otto-Knapp, T BauerPneumologie (Stuttgart, Germany)|August 31, 2018
[Migration and Tuberculosis]J T Othmer, N Schönfeld, B Häcker, et al.Pneumologie (Stuttgart, Germany)|November 17, 2020
[The New WHO Guidelines for Rapid Diagnostics and Treatment of Drug-Resistant Tuberculosis Commented for Germany, Austria and Switzerland]R Otto-Knapp, M Knappik, B Häcker, et al.IJTLD Open|January 19, 2026
Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocolM Gödecke, F Eberhardt, G Barten-Neiner, et al.Pneumologie (Stuttgart, Germany)|February 18, 2021
Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha BiologicalsR Diel, T Schaberg, A Nienhaus, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 1, 2003
Antioxidative enzymes in human nasal mucosa after exposure to ozone. Possible role of GSTM1 deficiencyR Otto-Knapp, K Jurgovsky, K Schierhorn, et al.Pneumologie (Stuttgart, Germany)|July 10, 2014
[Resistance to second-line drugs in migrants with multidrug-resistant tuberculosis in the Berlin region]R Otto-Knapp, L Bös, N Schönfeld, et al.Pulmonary Pharmacology & Therapeutics|May 4, 2007
Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthmaR Otto-Knapp, F Conrad, S Hösch, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 5, 2019
Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic reviewY Hamada, N Ford, K Schenkel, et al.Pageof 52